rs2282991

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001145306.2(CDK6):​c.537+9859A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.923 in 152,274 control chromosomes in the GnomAD database, including 64,999 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.92 ( 64999 hom., cov: 32)

Consequence

CDK6
NM_001145306.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.595

Publications

8 publications found
Variant links:
Genes affected
CDK6 (HGNC:1777): (cyclin dependent kinase 6) The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017]
CDK6 Gene-Disease associations (from GenCC):
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microcephaly 12, primary, autosomal recessive
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK6NM_001145306.2 linkc.537+9859A>T intron_variant Intron 4 of 7 ENST00000424848.3 NP_001138778.1 Q00534
CDK6NM_001259.8 linkc.537+9859A>T intron_variant Intron 4 of 7 NP_001250.1 Q00534
CDK6XM_047419716.1 linkc.537+9859A>T intron_variant Intron 4 of 7 XP_047275672.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK6ENST00000424848.3 linkc.537+9859A>T intron_variant Intron 4 of 7 1 NM_001145306.2 ENSP00000397087.3 Q00534
CDK6ENST00000265734.8 linkc.537+9859A>T intron_variant Intron 4 of 7 1 ENSP00000265734.4 Q00534
CDK6ENST00000473078.1 linkn.85+9859A>T intron_variant Intron 1 of 1 2

Frequencies

GnomAD3 genomes
AF:
0.923
AC:
140408
AN:
152156
Hom.:
64947
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.983
Gnomad AMI
AF:
0.975
Gnomad AMR
AF:
0.832
Gnomad ASJ
AF:
0.978
Gnomad EAS
AF:
0.927
Gnomad SAS
AF:
0.885
Gnomad FIN
AF:
0.899
Gnomad MID
AF:
0.987
Gnomad NFE
AF:
0.908
Gnomad OTH
AF:
0.932
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.923
AC:
140518
AN:
152274
Hom.:
64999
Cov.:
32
AF XY:
0.920
AC XY:
68478
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.983
AC:
40858
AN:
41566
American (AMR)
AF:
0.832
AC:
12714
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.978
AC:
3397
AN:
3472
East Asian (EAS)
AF:
0.927
AC:
4792
AN:
5172
South Asian (SAS)
AF:
0.885
AC:
4264
AN:
4820
European-Finnish (FIN)
AF:
0.899
AC:
9539
AN:
10612
Middle Eastern (MID)
AF:
0.986
AC:
290
AN:
294
European-Non Finnish (NFE)
AF:
0.908
AC:
61801
AN:
68026
Other (OTH)
AF:
0.933
AC:
1974
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
546
1091
1637
2182
2728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.912
Hom.:
7874
Bravo
AF:
0.922
Asia WGS
AF:
0.913
AC:
3178
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.5
DANN
Benign
0.31
PhyloP100
0.59
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2282991; hg19: chr7-92345081; API